Detection of circulating tumor DNA in pancreas cancer.

Authors

Daniel King

Daniel King

Stanford University, Palo Alto, CA

Daniel King , Ash A. Alizadeh , George A. Fisher Jr.

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Hepatobiliary Cancer, Neuroendocrine/Carcinoid, Pancreatic Cancer, and Small Bowel Cancer

Track

Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Pancreatic Cancer,Small Bowel Cancer,Other GI Cancer

Sub Track

Diagnostics

Citation

J Clin Oncol 38, 2020 (suppl 4; abstr 645)

Abstract #

645

Poster Bd #

G20

Abstract Disclosures

Similar Posters

Poster

2020 Gastrointestinal Cancers Symposium

Impact of <i>CDKN2A/b</i> status in pancreatic cancer (PC).

Impact of CDKN2A/b status in pancreatic cancer (PC).

First Author: Kaitlin Annunzio

Poster

2019 Gastrointestinal Cancers Symposium

Whole-exome sequencing in unresectable pancreatic cancer patients with long-term survival.

Whole-exome sequencing in unresectable pancreatic cancer patients with long-term survival.

First Author: Kentaro Sudo

First Author: Hani M. Babiker

Poster

2014 ASCO Annual Meeting

Circulating tumor DNA (ctDNA) as a marker of recurrence risk in stage II colon cancer (CC).

Circulating tumor DNA (ctDNA) as a marker of recurrence risk in stage II colon cancer (CC).

First Author: Jeanne Tie